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Abstract Tartrate-resistant acid phosphatase (TRAP) is
known as an osteoclast marker, but osteoblasts and osteo-
cytes in the vicinity of bone remodeling sites also express
TRAP. Cell culture studies suggest that osteoblasts endo-
cytose osteoclastic TRAP for inactivation. To evaluate
whether changes in osteoclast activity could alter TRAP
expression in osteoblasts and/or osteocytes in vivo, we
studied the ovariectomized and vitamin D-deficient rat
(Ovx-D) and rats healing from rickets. Bone sections were
analyzed for TRAP gene expression by in situ hybridiza-
tion, TRAP protein by immunogold labeling, and TRAP
enzyme activity using the fluorescent substrate ELF97.
Osteoblasts and osteocytes close to intracortical remodel-
ing sites and bone surfaces demonstrated TRAP, most
prominently in cancellous bone and osteocytes. Intracel-
lular TRAP was located to electron-dense vesicles with
similar morphology in both cell types. Ovx-D increased
osteoclast activity (p \ 0.001) and ELF97? osteocytes
(p \ 0.05) in cancellous bone, but no corresponding
increase was observed in the osteocyte lacunar area. The
level of TRAP? vesicles in cortical osteoblasts (p \ 0.01)
in Ovx-D rats was also increased. Enhanced osteoclast
activity was noted in healing rickets after 72 h (p \ 0.05),
but no differences in TRAP expression were detected in
osteoblasts or osteocytes. Thus, increased osteoclast
activity does not affect TRAP expression in osteoblasts and
osteocytes, favoring the notion that increased TRAP in
these cells is rather due to increased synthesis. Although
the role of TRAP in osteoblasts and osteocytes remains
elusive, we speculate that the function is related to the
capability of the enzyme to regulate the phosphorylation of
proteins known to be expressed by these cells.
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Introduction
Tartrate-resistant acid phosphatase (TRAP; ACP5, EC
3.1.3.2)—also known as purple acid phosphatase, uterofer-
rin, or type 5 acid phosphatase [1]—has been an established
marker for osteoclasts and bone resorption for more than
50 years. TRAP is synthesized as a relatively inactive pro-
enzyme (monomeric TRAP [mTRAP], loop-TRAP, serum
TRAP 5a), and proteolytic cleavage by members of the
cathepsin family or other proteinases increases the catalytic
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activity at least tenfold [2, 3]. Cleaved, active TRAP is
identical to osteoclastic TRAP and serum TRAP 5b [4] and is
able to dephosphorylate bone matrix proteins, e.g., osteo-
pontin (OPN) and integrin binding sialoprotein (IBSP) [5, 6],
as well as to generate reactive oxygen species for bone matrix
degradation [7]. Halleen et al. [8] have shown that the serum
activity of TRAP 5b is significantly elevated in patients with
osteoporosis and negatively correlated with bone mineral
density (BMD). Studies on mice have yielded similar results:
global deletion of TRAP leads to disturbed endochondral
ossification and a mild osteopetrotic phenotype [9, 10], while
overexpression of TRAP results in enhanced bone turnover
and a mild osteoporotic phenotype [11]. In addition to
osteoclasts, TRAP has been reported in osteoblasts and
osteocytes [12–21] closely related to bone surfaces [12, 21]
or intracortical remodeling sites [12, 16] in rat bone tissue.
The origin and function of TRAP in these cells have been
debated; one hypothesis is that osteoclastic TRAP from the
resorption lacunae is endocytosed by the osteoblasts and/or
osteocytes. This theory is supported by cell culture studies
reporting that osteoblast-like cells are able to engulf osteo-
clastic TRAP and inactivate the enzyme, suggesting that this
could control the enzyme activity and prevent further deg-
radation of matrix constituents [17, 18]. However, endoge-
nous TRAP synthesis has been demonstrated in osteoblasts
[21] and in osteocytes [16] in areas close to bone-resorbing
osteoclasts, suggesting that TRAP may take part in mecha-
nisms controlling the direction of osteoclastic bone resorp-
tion [16]. Qing and coworkers [19] have demonstrated
enlarged osteocyte lacunae and canaliculi and increased
amounts of TRAP and cathepsin K in osteocytes in lactating
mice, suggesting that osteocytes are able to remodel their
own matrix environment through osteoclast-like mecha-
nisms under specific conditions.
To increase the knowledge of TRAP in osteoblasts and
osteocytes, we analyzed two experimental rat models with
disturbed bone metabolism to investigate whether changes in
osteoclast activity could alter TRAP protein expression and
enzyme activity in osteoblasts and/or osteocytes in vivo. The
ovariectomized and vitamin D-depleted rat (Ovx-D) mimics
human osteoporosis as seen in elderly postmenopausal
women with reduced BMD of metaphyseal bone [22].
Osteoclast activity and TRAP protein expression in osteo-
blasts and TRAP activity in osteocytes were increased in Ovx-
D rats. Moreover, Ovx-D rats presented a tendency toward
increased TRAP mRNA expression in osteocytes, questioning
the hypothesis of endocytosis being the mechanism enhancing
TRAP protein expression and enzyme activity in osteoblasts
and osteocytes in these rats. To further address this question,
rats healing from nutritionally induced low-phosphate and
vitamin D-deficiency rickets (experimental rickets) were
analyzed as a model of increased osteoclast activity [23].
However, such rats did not show any differences in the level of
TRAP protein expression or enzyme activity either in osteo-
blasts or in osteocytes, making it less likely that osteoblasts
and osteocytes endocytose osteoclastic TRAP.
Materials and Methods
All analyses were performed on coded sections using
AnalySIS FIVE (Olympus Soft Imaging Solutions, Mu¨n-
ster, Germany) following the suggestions for standardized
nomenclature from the American Society for Bone and
Mineral Research [24].
Animal Experiments
The Guide for the Care and Use of Laboratory Animals
[25] was followed, and the study protocols were approved
by the Norwegian National Animal Research Authority.
The Ovx-D model has been reported in detail previously
[22]. Low-phosphate and vitamin D-deficiency rickets and
healing for 48 and 72 h were induced as described by
Hollberg et al. [23]. Blood was sampled from the animals,
and their tissues were fixed by vascular perfusion [22] at
the end of the experiments.
Tissue Preparation
Femurs and tibias were dissected free, immersed in 2 %
phosphate-buffered paraformaldehyde, and decalcified in 7 %
EDTA with 0.5 % paraformaldehyde for 40 days. Bone tis-
sues for light microscopy or fluorescence microscopy were
paraffin-embedded, and 2–3-lm-thick sections were cut,
picked up on glass slides, and rehydrated through a series of
graded alcohols. Bone tissues for transmission electron
microscopy (TEM) were cut into small samples (*1 mm3),
fixed in 2 % paraformaldehyde and 0.5 % glutaraldehyde, and
embedded with progressive lowering of temperature (Leica
EM AFS; Leica Microsystems, Wetzlar, Germany) in the
acrylate- and methacrylate-based resin Lowicryl HM23
according to our established protocol [26]. Ultrathin sections
(75 nm) were mounted on formvar-coated nickel slot grids.
Osteoclast Activity
Total numbers of osteoclasts relative to tissue volume
(N.Oc/TV) and osteoclast surface relative to bone surface
(Oc.S/BS) were estimated by point counting in a squared
grid within 500 lm from the epiphyseal/metaphyseal bor-
der (EMB) at TEM micrographs. An osteoclast was defined
as a multinuclear cell attached to a bone surface or in the
intertrabecular space with characteristics such as ruffled
border, intracytoplasmic vesicles, and abundant mito-
chondrial profiles. Twenty micrographs from each animal
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were analyzed, and the ratio (Oc.S/BS)/(N.Oc/TV) was
calculated for each animal and compared between Ovx-D
and sham as a parameter of osteoclast activity [27]. In the
experimental rickets group, commercially available kits
were used for determination of osteoclast-derived C-telo-
peptide fragments of collagen type I (CTX) (RatLapsTM
EIA; Immunodiagnostic Systems, Tyne and Wear, UK) and
osteoclast-derived TRAP 5b (RatTRAPTM Assay, Immu-
nodiagnostic Systems). Serum was analyzed in all animals,
and the CTX/TRAP 5b ratio, as a parameter for osteoclast
activity [27], was calculated for each animal and compared
between the groups.
In Situ Hybridization
TRAP gene expression was studied by in situ hybridiza-
tion. A gene sequence for rat TRAP [28] was amplified by
conventional PCR using cDNA from rat bone and oligo-
nucleotide forward and reverse primers: rnTRAP.for 50-AC
GCCAATGACAAGAGGTTC-30, rnTRAP.rev 50-ACATA
GCCCACACCGTTCTC-30 (Life Technologies, Carlsbad,
CA, USA) and cloned in a Dual Promoter TA Cloning Kit
(Life Technologies). The cloned insert was sequenced to
establish the orientation (Seqlab, Go¨ttingen, Germany). A
digoxigenin (DIG)–conjugated complementary RNA probe
was synthesized using T7 or Sp6 polymerase to yield the
probe in the sense or antisense direction (DIG-labeling kit;
Roche Diagnostics, Oslo, Norway). Longitudinal sections
from the tibial diaphysis (Ovx-D/sham) and femoral
diaphysis (experimental rickets) were subjected to hybrid-
ization following our established protocol [29]. TRAP
mRNA? osteocytes were quantified in cortical bone within
4–10 mm from the proximal EMB by point counting in a
squared grid. Three sections were examined from each
animal and their means compared between the groups.
Tibial diaphyses were examined twice with an interclass
correlation of p \ 0.001 and Cronbach’s alfa of 0.94.
Staining of osteoclasts from the femoral metaphysis in
healing for 72 h was used as a positive control. The sense
probe did not show any staining.
Immunofluorescence
To estimate TRAP enzyme activity and the putative colo-
calization of the translated mTRAP protein and the enzyme
activity, fluorescence-based staining with rabbit anti-
mTRAP and ELF97 was performed. With low pH (\6.0)
ELF97 is cleaved by activated acid phosphatase, yielding a
bright yellow–green fluorescence precipitate [30, 31]. Rabbit
anti-mTRAP was the same as previously used [32]. The
ELF97 Endogenous Phosphatase Detection kit, Alexa-
Flour555 conjugated secondary antibody, and DAPI Nucleic
Acid Stain were purchased from Molecular Probes (Eugene,
OR, USA). Longitudinal sections from distal femoral
metaphysis and diaphysis were analyzed. Images were
obtained by Nikon DS-Fi2 color camera (Nikon Instruments,
Melville, NY, USA) using UV and Cy3 filters and added in
ImageJ [33]. ELF97? osteocytes (Ot), mTRAP? Ot,
ELF97mTRAP? Ot, and total Ot were quantified in can-
cellous bone within 1 mm into the metaphysis from the
proximal EMB and in cortical bone within 4–10 mm from
the proximal EMB. The means were calculated for each
animal with respect to the parameters above and used for
comparison between the groups. Nonspecific rabbit IgG
served as a negative control for mTRAP, while TRAP
enzyme was inactivated using 100 lM molybdate before
adding ELF97 to evaluate the background fluorescence.
Immunogold Labeling for TEM
To evaluate the distribution of TRAP in osteoblasts and
osteocytes, bone sections from the tibial diaphysis (Ovx-D/
sham) and the proximal tibial metaphysis and diaphysis
(experimental rickets) were labeled with rabbit anti-TRAP
(SB-TR103, Immunodiagnostic Systems). Immunogold
labeling was performed as earlier described [34]. Nonspecific
rabbit IgG served as a negative control. Micrographs from
10–20 osteoblasts and osteocytes were randomly sampled
from each animal. An osteoblast was defined as a mononu-
clear cell attached to osteoid with prominent endoplasmatic
reticulum (ER) and Golgi complexes. An osteocyte was
defined as a mononuclear cell embedded in bone matrix with
characteristic canaliculi. A TRAP? vesicle was defined as a
vesicle of moderate electron density containing four or more
gold particles. An area of TRAP? vesicles (TRAPv.Ar) rela-
tive to the area of cytoplasm (Cy.Ar) was measured in each
osteoblast and osteocyte and the mean of the ratios (TRAP-
v.Ar/Cy.Ar) for each animal compared between the groups.
Cells were analyzed twice with respect to TRAPv.Ar/Cy.Ar
with an interclass correlation of p \ 0.001 and Cronbach’s
alfa of 0.98. Large standard deviations (SDs) in the ratios were
observed for both osteoblasts and osteocytes within the Ovx-D
and sham groups. To elucidate whether this phenomenon was
due to differences between the animals in each group or in
each animal, eight bone levels in one animal from each group
were examined. The results demonstrated that the large SDs
between the animals corresponded to the SDs between bone
levels in each animal, indicating large biological variation
(data not shown).
Measurements of the Extent of TRAP? Osteocytes
Semiquantitative measurements were performed on sections
subjected to in situ hybridization or immunofluorescence in
order to estimate the distance from bone surfaces or bone
remodeling surfaces toward osteocytes expressing TRAP
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mRNA, TRAP protein (mTRAP), or TRAP enzyme activity
in cancellous and cortical bone. All animals subjected to
TRAP mRNA in situ hybridization as well as three animals
from each group in both cancellous and cortical bone sub-
jected to fluorescence-based staining with mTRAP and the
fluorescence substrate ELF97 were analyzed.
Osteocyte Lacunar Area
Longitudinal tibia mid-diaphyseal sections from Ovx-D and
sham animals at the same bone level were subjected to con-
ventional hematoxylin–eosin–saffron (HES) staining. The
osteocyte lacunar area was measured within 1 mm at three
discrete sites separated by 1 mm in a cross-sectional manner.
Both cortices were included, and 200–250 osteocytes were
measured per animal. The means of the osteocyte lacunar area
were calculated and compared between the groups.
Statistics
Statistical analyses were performed in PASW Statistics 18
(SPSS, Inc., Chicago, IL, USA). Parametric tests were used
to compare the measured data, Student’s t test for two
variables and one-way analyses of variance (ANOVA) for
k variables. Nonparametric tests, Mann–Whitney for two
variables, and Kruskal–Wallis for k variables were applied
to the semiquantitative data. A p value of 0.05 was con-
sidered significant in all tests.
Results
Animal Models
Ovx-D rats developed osteoporosis with reduced trabecular
bone volume (BV/TV) in the femoral head, p \ 0.001, and
decreased BMD in the femoral neck and the lower lumbar
vertebra, p \ 0.001 (Online Resource 1a, b) as well as
undetectable serum levels of 25(OH)D and serum estradiol
within the human postmenopausal range [22]. Low-phos-
phate and vitamin D-deficiency rickets with characteristic
morphological changes (Online Resource 1c) were in line
with previous experience with the model [23].
Enhanced Osteoclast Activity in Animal Models
To evaluate TRAP positivity in osteocytes and osteoblasts
in relation to osteoclast activity, we calculated osteoclast
activity as Oc.S/BS relative to N.Oc/TV and CTX relative
to TRAP 5b in serum in Ovx-D/sham and experimental
rickets, respectively. Increased osteoclast activity was
observed in Ovx-D versus sham (Fig. 1a) as well as in
healing rickets after 72 h compared to fulminant rickets
and normal controls, reflecting the healing of the growth
plate with enhanced resorption monitored by an increased
CTX/TRAP 5b ratio in serum (Fig. 1b).
TRAP is Increased in Osteoblasts and Osteocytes
in Ovx-D
In cancellous bone ELF97? Ot/Ot and colocalized
ELF97mTRAP? Ot/Ot were increased in Ovx-D versus
sham (Figs. 2, 3a). Ovx-D also demonstrated a tendency to
increase in ELF97? Ot/Ot and ELF97mTRAP? Ot/Ot
versus sham in cortical bone (Online Resource 2, Fig. 3b).
TEM analyses showed TRAP in intracellular electron-
dense vesicles (200–500 nm in diameter) with similar
morphological features in both osteoblasts and osteocytes
in cortical bone. However, no general pattern of location in
the cytoplasm was detected, and we were not able to
demonstrate any fusion between TRAP? vesicles and the
cell membrane or any coated pits at the cell surface con-
taining TRAP (Fig. 4a–h). Semiquantitative measurements
of the area of TRAP? vesicles relative to total cytoplasmic
area (TRAPv.Ar/Cy.Ar) showed an increased ratio in
osteoblasts and osteocytes in Ovx-D compared with sham,
Fig. 1 Osteoclast activity. a The ratio of (Oc.S/BS)/(N.Oc/TV) in
cancellous bone was increased in Ovx-D versus sham (Student’s
t test, n = 7 for both). b The ratio of serum CTX/TRAP 5b was
increased in healing for 72 h compared with fulminant rickets (R) and
controls (C) (ANOVA, n = 7 for all). aResults are presented with
mean and SD, *p \ 0.05, ***p \ 0.001
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Fig. 2 TRAP enzyme activity and monomeric TRAP (mTRAP)
immunolabeling in osteocytes (Ot) in cancellous bone from distal
femoral metaphysis. HES stained sections show the tissue architecture
of cancellous bone in a sham and e Ovx-D. Boxes indicate areas
corresponding to the immunofluorescence images. ELF97? Ot
(yellow-green, arrows), mTRAP? Ot (red), and ELF97mTRAP? Ot
(arrowheads) in b–d sham and f–h Ovx-D. i Inhibition of TRAP
enzyme activity with molybdate demonstrated low background
fluorescence for ELF97. j Unspecific rabbit IgG served as negative
control for mTRAP with low background fluorescence. k A high-
power image shows the staining of ELF97 and mTRAP in osteocytes.
Scale bars 10 lm
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significant in osteoblasts (Fig. 4i). In situ hybridization
demonstrated TRAP mRNA in osteocytes in cortical bone
close to bone surface and intracortical remodeling sites in
both Ovx-D and sham animals (Fig. 5a–c). However, only
a small proportion of osteocytes in cortical bone were
TRAP mRNA?: 2.9 % in Ovx-D versus 0.09 % in sham.
Although the difference appeared striking, the result was
not statistically significant (Fig. 5e).
Healing from Rickets Does Not Alter TRAP
in Osteoblasts or Osteocytes
No difference was detected in TRAP enzyme activity
(ELF97? Ot/Ot), mTRAP? Ot/Ot or ELF97mTRAP? Ot/
Ot in either cancellous or cortical bone in any of the groups
in the experimental rickets model (Fig. 6). TRAP? vesicles
were observed in both osteoblasts and osteocytes in can-
cellous bone and presented similar features as in osteo-
blasts and osteocytes in the experimental osteoporosis
model. However, there was no difference in the ratio
TRAPv.Ar/Cy.Ar between the groups. In cortical bone
only a few TRAP? vesicles were observed in osteocytes
and none in osteoblasts. TRAP mRNA in situ hybridization
in the femoral diaphysis failed to demonstrate TRAP
mRNA? osteocytes in any of the groups, despite staining in
the metaphyseal osteoclasts used as positive controls (data
not shown) and with no staining for the sense probe.
TRAP? Vesicles Are More Abundant in Osteocytes
Compared with Osteoblasts
TEM revealed increased TRAPv.Ar/Cy.Ar ratios in
osteocytes versus osteoblasts in cancellous bone for ani-
mals in the experimental rickets model: p \ 0.05 (rickets
and controls), p \ 0.01 (healing after 48 h) (Online
Resource 3a). In cortical bone, osteocytes from Ovx-D and
sham rats also demonstrated increased TRAPv.Ar/Cy.Ar
ratios versus osteoblasts, significant in sham, p \ 0.001
Fig. 3 TRAP enzyme activity in osteocytes in cancellous and cortical
bone in the experimental osteoporosis model. a ELF97? Ot/Ot and
ELF97mTRAP? Ot/Ot were significantly increased in Ovx-D versus
sham in cancellous bone, b while there were no significant differences
between the groups in cortical bone (Mann–Whitney test, n = 7 for
both). aResults are presented with mean and SD, *p \ 0.05
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(Online Resource 3b). Only a small number of TRAP?
vesicles were detected in cortical osteocytes and none in
cortical osteoblasts in the experimental rickets model.
TRAP Activity in Osteoblasts and Osteocytes Is Most
Prominent in Cancellous Bone
TRAP enzyme activity in osteocytes (ELF97? Ot/Ot) was
increased in cancellous versus cortical bone in all groups
from both animal models, p \ 0.01 (Ovx-D, sham, rickets,
healing after 48 h, and controls), p \ 0.05 (healing after
72 h) (Online Resource 4a). The vesicle ratio TRAPv.Ar/
Cy.Ar was increased in cancellous versus cortical bone in
osteoblasts and osteocytes in all animals in the experimental
rickets groups: Ot, p \ 0.001 (rickets and healing after
48 h), p \ 0.05 (healing after 72 h), p \ 0.01 (controls); Ob,
p \ 0.001 (rickets, healing after 48 h and controls), p \ 0.01
(healing after 72 h) (Online Resource 4b, c).
Fig. 4 TEM micrographs from tibial diaphysis in Ovx-D and sham.
Images with overview and close-ups show examples of immunogold
labeling for TRAP in intracellular vesicles in osteoblasts (Ob) and
osteocytes (Ot) in cortical bone: a, b osteocyte and c, d osteoblast
from Ovx-D and e, f osteocyte from sham with TRAP? vesicles. g,
h Unspecific rabbit IgG served as negative control and did not label
the vesicles in Ovx-D. i Significantly increased TRAP vesicle area
versus area of cytoplasm (TRAPv.Ar/Cy.Ar) ratio in osteoblasts in
Ovx-D versus sham (Mann–Whitney test, n = 7 for both). a Results
are presented with mean and SD, **p \ 0.01
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TRAP? Osteocytes Are Close to Bone Surface or Bone
Remodeling Surfaces
TRAP mRNA? osteocytes in cortical bone and osteocytes
demonstrating mTRAP and ELF97 positivity in cancellous
and cortical bone were found in areas closely related to the
bone surface or intracortical remodeling surfaces. The
mean distance from TRAP mRNA? osteocytes to the bone
surface or intracortical remodeling surfaces was 33 lm,
and all TRAP mRNA? osteocytes were found within
148 lm from the bone surface or intracortical remodeling
surfaces. mTRAP? osteocytes and ELF97? osteocytes in
Fig. 5 In situ hybridization for TRAP mRNA in tibial diaphysis in
Ovx-D and sham animals. a TRAP mRNA? osteocytes (Ot, arrows)
were stained dark blue and observed to be closely related to the bone
surface (BS) and the bone remodeling surface (Rm.S) in Ovx-D.
b Sham animals demonstrated a limited number of TRAP mRNA?
osteocytes (arrows) c The method was confirmed by positive staining
of an osteoclast in a bone morphogenic unit (BMU) with TRAP
mRNA? osteocytes (arrows) in close vicinity (Ovx-D). *Central
capillary. d The sense probe displayed no staining and served as a
negative control. e There was no significant difference in TRAP-
mRNA? Ot/ Ot between Ovx-D and sham (Mann–Whitney test,
n = 7 for both). a Results are presented with mean and SD
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metaphyseal bone were 24 and 16 lm away from the bone
surface (mean values) and no farther away than 104 and
116 lm, respectively. In cortical bone the mean distances
were 60 and 27 lm, respectively, and all the TRAP?
osteocytes were within 166 and 113 lm, respectively.
However, as these semiquantitative estimations were per-
formed on two-dimensional sections, we cannot exclude
that the real distance from the TRAP? osteocytes to the
bone surface or bone remodeling surfaces was shorter in
another direction.
No Difference in Osteocyte Lacunar Area in Cortical
Bone in Ovx-D versus Sham
To elucidate whether the increased level of TRAP in
osteocytes in Ovx-D rats could be related to increased local
resorption as described for lactating mice [19], osteocyte
lacunar area in cortical bone was measured; but no dif-
ference was detected between the groups (Fig. 7).
Discussion
Osteoclastic TRAP has been demonstrated in transcytotic
intracellular vesicles as well as in the ruffled border
beneath the osteoclast during active bone resorption [7, 23,
29, 35, 36]. The secretion of TRAP from the osteoclast to
the resorption lacuna makes TRAP available for other bone
cells, and TRAP has been suggested as one of the ‘‘cou-
pling factors’’ between bone resorption and bone formation
[37]. Previous studies have demonstrated TRAP in osteo-
blasts and osteocytes in areas close to active bone resorp-
tion sites [12, 16, 21], which has led to the hypothesis that
osteoblasts and/or osteocytes engulf osteoclastic TRAP for
inactivation [17]. We tested this hypothesis in vivo by
analyzing TRAP expression in osteoblasts and osteocytes
in two animal models with increased osteoclast activity: the
experimental osteoporotic rat and rats healing from diet-
induced rickets. In both models osteocytes and osteoblasts
in cancellous bone and in cortical bone close to intracor-
tical remodeling sites and endosteal/periosteal surfaces
demonstrated TRAP gene expression and translation to
protein as well as TRAP enzyme activity, no farther away
than 166 lm. This is in line with the observations made by
Nakano et al. [16], who demonstrated TRAP? osteocytes in
rat bone in the range of 200 lm from the resorption sur-
faces and concluded that there is a close relation between
TRAP? osteocytes and bone resorption. TEM analyses
revealed TRAP in intracellular vesicles with identical
morphological features in osteoblasts and osteocytes in all
animals in both experimental models. This observation
indicates that TRAP in osteoblasts and osteocytes might be
located to endosomes, involved in intracellular transport, or
stored in vesicular compartments for secretion. Moreover,
Fig. 6 TRAP enzyme activity in osteocytes (Ot) in a cancellous and
b cortical bone in the experimental rickets model demonstrated no
significant differences between the groups; fulminant rickets (R),
healing for 48 h, healing for 72 h, and controls (C) (Kruskali–Wallis
test, n = 7 for all). a Results are presented with mean and SD
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the Ovx-D group demonstrated an increased ratio of
TRAP? vesicles in osteoblasts in cortical bone and
increased TRAP enzyme activity in osteocytes in cancel-
lous bone, and we also observed a tendency to enhanced
levels of TRAP gene expression in osteocytes in cortical
bone. These results indicate that the observed increase in
TRAP protein expression and enzyme activity in osteo-
blasts and osteocytes is due to increased synthesis and not
increased osteoclast activity. Moreover, no changes were
demonstrated between the animals in the different groups
in the experimental rickets model regarding TRAP in
osteoblasts and osteocytes, despite the increased osteoclast
activity in rats healing for 72 h. Thus, enhanced osteoclast
activity does not change TRAP expression in vivo in
osteoblasts or osteocytes in our models. Consequently, the
TRAP observed in osteoblasts and osteocytes is not
engulfed osteoclastic TRAP but rather synthesized in the
respective cells. The theory of osteoblast and osteocyte
endocytosis of osteoclastic TRAP [17] is therefore not
supported by our results. A similar conclusion has been
drawn by Bonucci et al. [13]: they observed that the
increased level of TRAP? osteoblasts in calcium-depleted
rats returned to normal when calcium was replaced despite
unchanged levels of TRAP? osteoclasts.
Comparison of TRAP expression in cancellous versus
cortical bone demonstrated enhanced levels of TRAP
enzyme activity in osteocytes in all animal groups as well
as an increase in the ratio of TRAP? vesicles in osteoblasts
and osteocytes in animals in the experimental rickets
groups. There is an obvious structural difference between
cancellous and cortical bone, and cancellous bone appears
to be more metabolically active than cortical bone with a
higher bone turnover. This might be explained by a greater
surface to volume ratio in cancellous versus cortical bone
[38]. The increase in TRAP? vesicles and enzyme activity
in osteoblasts and osteocytes in cancellous bone might
therefore be linked to bone turnover; however, the mech-
anism remains elusive.
Qing et al. [19] observed increased TRAP as well as
cathepsin K in osteocytes in lactating mice with a corre-
sponding increase in the osteocyte lacunar area. In a recent
study Kogawa et al. [39] showed that sclerostin increases
the expression of TRAP, cathepsin K, and carbonic anhy-
drase (CA2) in osteocytes with a resulting increase in the
osteocyte lacunar area. The effect is reversed by the CA2
inhibitor acetozolamide, which indicates that the osteocytic
osteolysis is at least partly dependent on CA2 and its
response to sclerostin. However, the effects of inhibition of
Fig. 7 a Cortical bone sections (tibial diaphyses) from Ovx-D and
sham animals were formalin-fixed, paraffin-embedded, and cut in
3-lm-thick sections before conventional HES staining was per-
formed. A clear definition of the osteocyte lacunar outline was
obtained after staining of tissue sections for both Ovx-D and sham.
This is demonstrated by the high-power images inserted. b There was
no difference in the osteocyte (Ot) lacunar area between Ovx-D and
sham animals (Student’s t test, n = 7 for both). a Results are
presented with mean and SD
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TRAP or cathepsin K on the osteocyte lacunar area were
not reported. Taken together, both lactation and sclerostin
seem to enhance TRAP expression in osteocytes as well as
ostocytic osteolysis. We investigated the effect of TRAP on
osteocytic osteolysis in the experimental osteoporosis
model but failed to demonstrate any difference in the
osteocyte lacunar area between Ovx-D and sham despite
increased osteocytic TRAP in the Ovx-D animals. An
explanation for this may be that we did our measurements
on decalcified tissue sections. However, this method has
been used by others with success [39]. Consequently, we
propose that osteocytic TRAP is not solely related to os-
teocytic osteolysis but has an additional role in osteocytes.
Our TEM observations of TRAP located to intracellular
vesicles with similar morphological features in both oste-
oblasts and osteocytes indicate that TRAP may have cor-
responding functions in the two cell types. Moreover,
osteoblasts do not normally dissolve bone mineral, and the
observed increase in osteoblastic TRAP in the Ovx-D
animals is therefore unlikely to be related to local mineral
handling by the osteoblasts. In conclusion, the role of
TRAP in osteoblasts and osteocytes remains elusive.
However, our results support the notion that TRAP may
have another, not yet clarified role in osteocytes, in addi-
tion to the suggested contribution in local mineral han-
dling. Results by our group indicate that the TRAP?
vesicles observed in osteoblasts and osteocytes also contain
RANKL and OPG [40]. This may explain why only oste-
oblasts and osteocytes in specific areas close to the bone
surface or bone remodeling surfaces demonstrate TRAP
synthesis and/or enzyme activity. We therefore propose
that the function of TRAP in osteoblasts and osteocytes
involves the capability of the enzyme to regulate, e.g.,
phosphorylation of proteins known to be expressed by
these cells with effects on RANKL and OPG.
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